null - FindTrial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2011-003390-29-DK

Enrollment

Registered

2011-08-23

Start date

2011-10-14

Completion date

Unknown

Last updated

2021-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.1 Level: LLT Classification code 10054711 Term: Postoperative pain System Organ Class: 10022117 - Injury, poisoning and procedural complications

Interventions

Trade Name: Ropivacain Product Name: Ropivacainhydrochlorid Product Code: 26616 Pharmaceutical Form: Infusion CAS Number: 98717-15-8 Other descriptive name: ROPIVACAINE HYDROCHLORIDE Pharmaceutical fo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 60 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: At vurdere gennemoptræningsforløb og stabilitet i høj tibiaosteotomi i forhold til henholdsvis infiltrationsanalgesi og femoralisblokade.;Primary end point(s):	—

Countries

Denmark

Contacts

Public ContactAnders Christian Laursen

Ortopædkirurgisk Forskningsenhed

anchla@rn.dk+4599322367

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026